Every month, I’ll be highlighting breast
cancer research that is going on RIGHT NOW! Harvested from different websites,
journals and podcasts, I’ll translate them into understandable English and
share them with you. Today: http://www.sciencedaily.com/releases/2013/06/130614081714.htm
(Yeah, I know, this seems to be the site
that highlights cutting edge breast cancer research – there’s SO much more
there, you should put it on your Favorites Bar and check it often! If you don’t
get something, I CAN translate (BS in biology, 33 years of experience teaching
science of all sorts, to kids of all sorts…from astronomy to zoology. I CAN
help!)
One of the most
horrifying pronouncements breast cancer survivors can hear comes AFTER the
initial diagnosis: “I’m sorry, the cancer has spread.”
“Why?”
“We don’t know
for certain, we only know that there are indications that you might have…bone
cancer…lung cancer…brain cancer…liver cancer…”
The post more
people have gone to on this blog is the one on brain cancer (admittedly, the
reason they go there is because more people GOOGLE “brain cancer” when they
have a bout of extended, unusual headaches than just about any other normal,
more average diagnosis – like dehydration…), and the 4-part series on
metastatic breast cancer garnered 7% of ALL the hits on this site (with 116
posts). This is a big deal!
So what’s new?
ROR1, is what.
Identified by a
team of researchers at the University of California, San Diego School of
Medicine and UC San Diego Moores Cancer Center, ROR1 is a (thankfully
shortened) acronym for “Receptor-tyrosine-kinase-like Orphan Receptor 1”.
And that is????
How to explain
this…OK – a baby develops from conception. How do an egg cell and a sperm cell
create heart, lung, and toe cells? The process of changing the sperm and egg
cell into the rest of a person, is controlled by family of molecules in the
growing baby called ROR1. I won’t get into the technical language regarding
this protein except to say that they “live” on the surface of cells and they
attract and hold lots and lots of growth controlling molecules, hormones and
other molecules carrying chemical messages from other parts of the body.
ROR1 is also
active at exactly two times in a human’s life: during the growth of the embryo
and during cancer cell growth.
The team doing
this research points out that the identification of ROR1 at these two times, “presents
a singular, selective target for anti-cancer therapies that would leave normal
cells unaffected.”
Normal cells
unaffected! Can you imagine that? No more hair loss! No more muscle weakness!
No more susceptibility to colds, flu, and every other disease known to
humanity!
This is NOT a
new therapy available today – but the research group suggests that “silencing
expression of ROR1 reverses...and inhibits the metastatic spread of breast
cancer cells in animal models. Moreover, the researchers found that treatment
with a monoclonal antibody [a compound made by humans that is specifically targeted
at a single, disease-causing organism. A cell poison for that organism could
ride along with the compound] targeting
ROR1 also could inhibit the growth and spread of highly metastatic tumors that
express ROR1.”
In other words,
they hope that women in the future diagnosed with metastatic breast cancer will
have a powerful recourse that will be less invasive than any of the other.
No comments:
Post a Comment